mephenesin has been researched along with Basal Ganglia Diseases in 1 studies
Mephenesin: A centrally acting muscle relaxant with a short duration of action.
1-(2-methylphenyl)glycerol : A glycerol ether in which a single 2-methylphenyl group is attached at position 1 of glycerol via an ether linkage.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WALCH, R | 1 |
| HOHEISEL, HP | 1 |
1 other study available for mephenesin and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Treatment of spastic and extrapyramidal fixed states with Byk M I].
Topics: Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Humans; Mephenesin; Movement Disorders; Musc | 1953 |